- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Dihydrouracil Dehydrogenase (NADP)
Total 1138 results
-
Duke UniversityAstraZenecaCompletedTriple Negative Breast CancerUnited States
-
Central European Society for Anticancer Drug ResearchUnknownSmall Cell Lung Cancer SCLCGermany
-
National Cancer Institute (NCI)WithdrawnNeoplasmsUnited States
-
Hospital do Rim e HipertensãoNot yet recruiting
-
Sarcoma Alliance for Research through CollaborationCompleted
-
AbbVieCompletedSmall Cell Lung CancerUnited States, Australia, Belgium, Canada, Czechia, France, Hungary, Korea, Republic of, Netherlands, Romania, Russian Federation, Spain
-
Merck Sharp & Dohme LLCCompleted
-
Mario Negri Institute for Pharmacological ResearchAstraZenecaUnknown
-
Pamela MunsterNational Cancer Institute (NCI)RecruitingBRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | ATM Gene Mutation | BRCA Mutation | Checkpoint Kinase 2 Gene MutationUnited States
-
National Cancer Centre, SingaporeMerck Sharp & Dohme LLC; National Medical Research Council (NMRC), SingaporeNot yet recruitingRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaSingapore
-
Fondazione Ricerca TraslazionaleRecruiting
-
Jennifer Lauren KamensGateway for Cancer ResearchRecruitingAcute Myeloid LeukemiaUnited States
-
Dana-Farber Cancer InstitutePfizerRecruiting
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid NeoplasmUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingSolid TumorsPoland, Korea, Republic of, United States, Argentina, Australia, Canada, Colombia, France, Germany, Guatemala, Israel, Italy, Japan, Latvia, Mexico, Peru, Puerto Rico, Romania, South Africa, Spain, Sweden, Turkey, Ukraine
-
MedSIRTerminatedAdvanced Breast CancerSpain
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)TerminatedSmoking | HealthyUnited States
-
Pamela MunsterQuantumLeap Healthcare CollaborativeTerminatedTriple Negative Metastatic Breast Cancer | BRCA-mutated Solid TumorUnited States
-
AbbVie (prior sponsor, Abbott)Completed
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...AstraZenecaRecruitingKidney Cancer | Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Kidney Cancer Metastatic | Renal CarcinomaUnited States
-
Royal Marsden NHS Foundation TrustEli Lilly and Company; AstraZeneca; Clovis Oncology, Inc.; MedImmune LLCRecruitingAdenocarcinoma of the Stomach | Adenocarcinoma of the Oesophagus | Adenocarcinoma of the Gastro-oesophageal JunctionUnited Kingdom
-
Institut fuer FrauengesundheitMerck Sharp & Dohme LLCActive, not recruitingBreast Cancer | Malignant Neoplasm of BreastGermany
-
University of PennsylvaniaBristol-Myers Squibb; GlaxoSmithKlineActive, not recruitingPancreatic AdenocarcinomaUnited States
-
PfizerTerminatedPancreatic CancerBelgium, United States, Singapore
-
Uppsala UniversityKarolinska University Hospital; Uppsala University Hospital; Elicera TherapeuticsRecruiting
-
CCTU- Cancer ThemeAstraZeneca; Cancer Research UK; University of CambridgeRecruiting
-
Gustave Roussy, Cancer Campus, Grand ParisMerck Sharp & Dohme LLCNot yet recruiting
-
Haukeland University HospitalRecruiting
-
pharmaand GmbHGilead SciencesTerminatedOvarian Cancer | Solid Tumor | Urothelial Carcinoma | Triple-negative Breast CancerUnited States
-
SanofiSOLTI Breast Cancer Research GroupCompletedBreast Cancer FemaleSpain, France, Germany
-
University of PennsylvaniaTesaro, Inc.; NovoCure Ltd.Active, not recruiting
-
Nordic Society of Gynaecological Oncology - Clinical...Massachusetts General Hospital; University of Utah; European Network of Gynaecological... and other collaboratorsCompletedOvarian CancerUnited States, Denmark
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedMalignant Solid TumorsUnited Kingdom
-
Vall d'Hebron Institute of OncologyRecruiting
-
Institute of Hematology & Blood Diseases HospitalNot yet recruitingTo Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation
-
AbbVieCompletedMetastatic Breast CancerUnited States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Hungary, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Mexico, Netherlands, Norway, Po... and more
-
University of OxfordAstraZenecaCompletedOvarian CancerUnited Kingdom
-
Mario Negri Institute for Pharmacological ResearchAstraZenecaRecruitingCarcinoma, Ovarian EpithelialItaly
-
L. Nicolas Gonzalez Castro, MD, PhDMerck Sharp & Dohme LLCRecruiting
-
Massachusetts General HospitalActive, not recruitingEwing Sarcoma | RhabdomyosarcomaUnited States
-
University Hospital, CaenCompleted
-
University of WashingtonAbbVieNo longer availableTriple-Negative Breast Cancer | Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic MutationUnited States
-
Bristol-Myers SquibbCompletedHepatitis CFrance, Germany, Italy, Japan, United States, Australia, Puerto Rico, Spain, New Zealand
-
Mary D ChamberlinDartmouth-Hitchcock Medical CenterNot yet recruitingMetastatic Breast Cancer
-
Nordic Society of Gynaecological Oncology - Clinical...Hellenic Cooperative Oncology Group; European Network of Gynaecological Oncological... and other collaboratorsRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
Cambridge University Hospitals NHS Foundation TrustAstraZeneca; Cancer Research UKRecruiting
-
AstraZenecaActive, not recruitingBreast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Germany, Austria, Israel, Australia